A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HHD / hypertensive heart disease

[Related PubMed/MEDLINE]
Total Number of Papers: 125
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HHD  (>> Co-occurring Abbreviation)
Long Form:   hypertensive heart disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease. CMR, ECV, LVH, LVMI, OPLS, PLS-DA
2019 Multiple Autoantibodies against Cardiovascular Receptors as Biomarkers in Hypertensive Heart Disease. ---
2019 Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study. CVD, IHD, UI
2019 Radiomic Analysis of Myocardial NativeT1 Imaging Discriminates BetweenHypertensive Heart Disease andHypertrophic Cardiomyopathy. HCM, LVWT, SVM, TA
2019 Recent Advances in Imaging of Hypertensive Heart Disease. CMR, ECV
2019 The role of fibroblast - Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease. CF, CM, CM-SF, ECC, HF, HFpEF, LA
2018 Alteration in microRNA-25 expression regulate cardiac function via renin secretion. DCM, HHDF, RAS
2018 Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis. CMO, HF, RHD, SSA
2018 Hypertension and atrial fibrillation: a bench to bedside perspective. AF, CV, HTN
10  2018 Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy. CMR, HCM, LGE, LV, LVMI, MLVWT, PFR, RV, TPF
11  2018 Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure. HF, LA, LV, SHR, SHR-NF, WKY
12  2017 Cardiovascular diseases and systolic function of left ventricle in clean up workers of Chernobyl accident (based on 30 years follow up). ARS, ChNPP, CW, EF, ESV, HF, IVS, LV, LVH, PW
13  2017 Comparison of Pulmonary Venous and Left Atrial Remodeling in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy Versus With Hypertensive Heart Disease. HC, LA, PV
14  2017 Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm. CMR, EDWT, HCM, LGE, LV, SAM
15  2017 MiR-19b and miR-16 cooperatively signaling target the regulator ADRA1A in Hypertensive heart disease. ADBP, Doca, HR, SBP
16  2017 Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction. HFpEF
17  2017 The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease. CMR, ECHO, HF, IHD, LVH
18  2016 Aircraft, road and railway traffic noise as risk factors for heart failure and hypertensive heart disease-A case-control study based on secondary data. ---
19  2016 Cardiac Fibrosis in Aortic Stenosis and Hypertensive Heart Disease Assessed by Magnetic Resonance T1 Mapping. AS, LGE
20  2016 Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance. EDWT, HCM, LVH
21  2016 Productivity costs and years of potential life lost associated with five leading causes of death: Evidence from Iran (2006-2010). CPL, CVD, GC, MI, TA, YPLL, YPPLL
22  2016 Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry. ED, ES, HCM, LV, MR
23  2016 [Diagnosis, Prognosis, Monitoring of Cardiac Complications of Arterial Hypertension. Hypertensive Heart Disease]. EH
24  2015 Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography. CA, EMT, HCM, LA, LV, STE
25  2015 Identification of molecular markers in patients with hypertensive heart disease accompanied with coronary artery disease. CAD, hs-CRP, oxLDL
26  2015 Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease. AUC, HCM, RV, TAM
27  2014 A custom correlation coefficient (CCC) approach for fast identification of multi-SNP association patterns in genome-wide SNPs data. CCC, SNPs
28  2014 Alterations in cardiac structure and function in hypertension. CV, LVH
29  2014 Arterial hypertension in patients with heart failure. ---
30  2014 Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease. AAV, SHRs
31  2014 Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria. CI, HHF, Holter ECG, HRV, T2DM
32  2014 Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors. ---
33  2014 Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry. AF, CA, CAD, CI, CM, OR, OR, SHD
34  2014 Serum levels of tenascin-C variants in congestive heart failure patients: comparative analysis of ischemic, dilated, and hypertensive cardiomyopathy. DCM, ELISA, ICM, TN-C
35  2014 Spectrum of Echocardiographic Abnormalities among 168 Consecutive Referrals to an Urban Private Hospital in South-Western Nigeria. CVD, HCM, RHD, TTE
36  2014 The role of imaging in hypertensive heart disease. CMR
37  2013 A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading. HF, LV
38  2013 Atrophic cardiomyocyte signaling in hypertensive heart disease. ALDOST, ER
39  2013 Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease. ALDOST, PBMC
40  2013 Gene expression profiles of peripheral blood mononuclear cells reveal transcriptional signatures as novel biomarkers of cardiac remodeling in rats with aldosteronism and hypertensive heart disease. ALDOST, PBMCs, RNA
41  2013 High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration. LV, PCR
42  2013 MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease. CA, HCM, LGE, LVH
43  2013 Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease. ALDOST, ATEN, NEB, NO
44  2013 Neuromodulation device therapy for treatment of hypertensive heart disease. ---
45  2013 Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? HF, LV, OPN
46  2013 Prevalence, clinical characteristics and outcome of pulmonary hypertension among admitted heart failure patients. HF, LV, LVEF, mPAP, PHT, SBP
47  2013 Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan. HCM, LVH
48  2013 Sex-age differences in association with particulate matter and emergency admissions for cardiovascular diseases: a hospital-based study in Taiwan. AOR, CVDs, IHD, PM, PSI
49  2013 The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. BMI, CVD, FPG, IHD, RRs, SBP, TC
50  2013 The clinical utility of echocardiography as a cardiological diagnostic tool in poor resource settings. RHD
51  2013 Valvular regurgitations may increase risk of arrhythmias in Nigerians with hypertensive heart failure. EF, HHF, LVH, SVT
52  2012 Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat. HF, LV, SHRs
53  2012 Relationship between left ventricular ejection fraction and mitral annular displacement derived by speckle tracking echocardiography in patients with different heart diseases. DCM, HCM, IHD, LVEF, MAD, STE, VHD
54  2012 Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease. AS, ECG, FD, HC
55  2011 Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? AH, HF, IL-6, IL-8, MCP-1, MMP2, MMP9, TIMP1
56  2011 The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease. HCM, LV
57  2011 The state of heart disease in Sudan. CVD, HTN, IHD, RHD, SHHS
58  2011 [Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases]. BMI, CHD, DCM, ELISA, HCM, IHD, NYHA, PHD, RCM, VHD
59  2010 Assessment of right ventricular systolic function using tricuspid annular-plane systolic excursion in Nigerians with systemic hypertension. RV, TAPSE
60  2010 Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies. ---
61  2010 Is there a role for echocardiography in intracerebral haemorrhage? HTN, LVH
62  2010 Prevention, diagnosis, and treatment of hypertensive heart disease. LVH
63  2010 Systemic inflammation and left atrial thrombus in patients with non-rheumatic atrial fibrillation. AF, CRP, LA, TEE
64  2009 Assessment of left ventricular diastolic function using color kinesis: differentiation between normal and pseudonormalized patterns. CK, CK-DI, E/A, EF, LV, PN
65  2009 Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease. ECG, LV, MIBG, PFR, SPECT, TPF, WR
66  2009 Real-time three-dimensional echocardiographic assessment of left ventricular remodeling index in patients with hypertensive heart disease and coronary artery disease. CAD, EDV, EDVepi, LVRI, NC
67  2008 Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease. ---
68  2008 Enhanced detection of genetic association of hypertensive heart disease by analysis of latent phenotypes. ---
69  2008 Risk factors, atrial fibrillation and thromboembolic events. AF
70  2007 ECM remodeling in hypertensive heart disease. ---
71  2007 Hypertensive heart disease mortality in Wisconsin, 1979-2004. ---
72  2007 Hypertrophic cardiomyopathy is associated with more severe left ventricular dyssynchrony than is hypertensive left ventricular hypertrophy. HCM, LV, LVH, SD, Trs
73  2007 Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases. CHF, DCM, HCM, IHD, MIBG, PVD, VTF, VVD, WR
74  2007 Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction. AnxA5, LVH
75  2006 31P-MR spectroscopic imaging in hypertensive heart disease. MRS
76  2006 Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. HF, LVH, LVH, PPARalpha, RT-PCR
77  2006 Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. ECG, HCM
78  2005 A case of IgA multiple myeloma: Nutritional perspective in diagnostic testing. ---
79  2005 Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients. 31P-MRS, AR, ATP, DCM, HCM, PCr
80  2005 Intramyocardial injection of fibroblast growth factor-2 plus heparin suppresses cardiac failure progression in rats with hypertensive heart disease. ANP, BNP, DS, FGF
81  2005 Validation of noncompaction criteria in dilated cardiomyopathy, and valvular and hypertensive heart disease. IVNC, NC
82  2005 [Characteristics of hypertensive cardiomyopathy in a population of hypertensive patients never treated]. DD, LV
83  2004 Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. HF, PIP
84  2004 Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. HF, LVH
85  2004 Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy. ANP, BNP, HCM
86  2004 Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats. LVH, P-V, SHR
87  2003 Demonstration of altered fibroblast contractile activity in hypertensive heart disease. Ang II, IRB, SHR, WKY
88  2003 Ventricular arrhythmias: Q-T prolongation and left ventricular hypertrophy in adult Nigerians with hypertensive heart disease. PVC, VA
89  2002 Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. ATP, DCM, LV, PCr
90  2002 Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure. CHF, ICD, IDCM, RVHD
91  2002 Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease. BP, LV
92  2002 Local cardiac renin-angiotensin system: hypertension and cardiac failure. RAS
93  2001 Cardioreparation in hypertensive heart disease. ---
94  2001 Effects of antihypertensive agents on the left ventricle: clinical implications. LVH
95  2001 Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. HNCM, HOCM
96  2001 Fibrosis and ischemia: the real risks in hypertensive heart disease. LVH
97  2000 Can serum carnitine levels distinguish hypertrophic cardiomyopathy from hypertensive hearts? HCM
98  2000 Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease. LVH
99  1999 Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. beta-AR, IgG, VHD
100  1999 Hypertensive heart disease. ECG, LVH, MRI